Chemoinformaics analysis of 2-Methylene-6-methyl-5,7-octadien-1-ol
Molecular Weight | 152.237 | nRot | 5 |
Heavy Atom Molecular Weight | 136.109 | nRig | 3 |
Exact Molecular Weight | 152.12 | nRing | 0 |
Solubility: LogS | -1.346 | nHRing | 0 |
Solubility: LogP | 1.438 | No. of Aliphatic Rings | 0 |
Acid Count | 0 | No. of Aromatic Rings | 0 |
Base Count | 0 | No. of Aliphatic Carbocycles Rings | 0 |
Atoms Count | 27 | No. of Aliphatic Hetero Cycles | 0 |
No. of Heavy Atom | 11 | No. of Aromatic Carbocycles | 0 |
nHetero | 1 | No. of Aromatic Hetero Cycles | 0 |
nBridge Head | 0 | No. Saturated Carbocycles | 0 |
No. of Hydrogen atom | 16 | No. of Saturated Hetero Cycles | 0 |
No. of Carbon atom | 10 | No. of Saturated Rings | 0 |
No. of Nitrogen atom | 0 | No. of Arom Atom | 0 |
No. of Oxygen atom | 1 | No. of Arom Bond | 0 |
nHA | 1 | APOL | 28.1707 |
nHD | 1 | BPOL | 16.0513 |
QED | 0.474 |
Synth | 3.491 |
Natural Product Likeliness | 3.238 |
NR-PPAR-gamma | 0.006 |
Lipinski | Accepted |
Pfizer | Accepted |
GSK | Accepted |
Golden Triangle | Rejected |
Pgp-inh | 0.002 |
Pgp-sub | 0 |
HIA | 0.003 |
CACO-2 | -4.396 |
MDCK | 0.0000325 |
BBB | 0.989 |
PPB | 0.440928 |
VDSS | 1.301 |
FU | 0.562996 |
CYP1A2-inh | 0.066 |
CYP1A2-sub | 0.16 |
CYP2c19-inh | 0.023 |
CYP2c19-sub | 0.514 |
CYP2c9-inh | 0.005 |
CYP2c9-sub | 0.279 |
CYP2d6-inh | 0.007 |
CYP2d6-sub | 0.874 |
CYP3a4-inh | 0.014 |
CYP3a4-sub | 0.216 |
CL | 7.884 |
T12 | 0.91 |
hERG | 0.009 |
Ames | 0.313 |
ROA | 0.062 |
SkinSen | 0.755 |
Carcinogencity | 0.891 |
EI | 0.993 |
Respiratory | 0.926 |
NR-Aromatase | 0.054 |
Antiviral | No |
Prediction | 0.937189 |